Hutzel Women's Hospital is one of the eight institutions that compose the Detroit Medical Center. The hospital itself is connected to Harper University Hospital, on the midtown Detroit campus of the Medical Center. It is the only hospital in Southeast Michigan dedicated to women's care.

During the past decade, Hutzel Womens Health Specialists conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hutzel Womens Health Specialists" #1 sponsor was "The George Washington University Biostatistics Center" with 3 trials, followed by "NCIC Clinical Trials Group" with 2 trials sponsored, "Ferring Pharmaceuticals" with 1 trials sponsored, "Noven Therapeutics" with 1 trials sponsored and "Pinnacle Pharmaceuticals, Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hutzel Womens Health Specialists" #1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 3 trials as a collaborator, "Grupo Espanol de Investigacion del Cancer de Mama" with 1 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 1 trials as a collaborator and "UNICANCER" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Hutzel Womens Health Specialists" are "Breast Cancer" (2 trials), "Abruptio Placentae" (1 trials), "Cerebral Palsy" (1 trials), "Cervical Length" (1 trials) and "Complications, Pregnancy" (1 trials). Many other conditions were trialed in "Hutzel Womens Health Specialists" in a lesser frequency.

Most popular intervention types in "Hutzel Womens Health Specialists" are "Drug" (8 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "17 alpha-hydroxyprogesterone caproate" (1 trials), "Betamethasone" (1 trials), "Brisdelle (paroxetine mesylate)" (1 trials), "GnRH iontophoretic transdermal Lutrepatch" (1 trials) and "Iron" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hutzel Womens Health Specialists" are 9 trials for "Female" genders.

Currently, there are NaN active trials in "Hutzel Womens Health Specialists". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Hutzel Womens Health Specialists, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Hutzel Womens Health Specialists, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".